Multivessel TALENT
A Randomized Controlled Trial to Compare the Safety and Efficacy of siroliMUs-eLuTIng Biodegradable Polymer ulTrA-thin Stent (SUPRAFLEX Cruz) and Everolimus-eLuting Biodegradable Polymer Stent (SYNERGY) in treatmENT for Three-vessel Coronary Artery Disease: Multivessel TALENT
Sponsor: National University of Ireland, Galway, Ireland
A NA clinical study on Arterial Occlusive Diseases and Cardiovascular Diseases, this trial is ongoing. The trial is conducted by National University of Ireland, Galway, Ireland and has accumulated 13 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
13 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting NA
-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Jan 2026 — Present [monthly]
Active Not Recruiting NA
-
Nov 2024 — Feb 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
May 2023 — May 2024 [monthly]
Recruiting NA
-
May 2022 — May 2023 [monthly]
Recruiting NA
-
Apr 2021 — May 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National University of Ireland, Galway, Ireland
For direct contact, visit the study record on ClinicalTrials.gov .